Zeltiq Aesthetics Inc (ZLTQ) Releases Earnings Results, Misses Expectations By $-0.08 EPS

Zeltiq Aesthetics Inc (ZLTQ) reported quarterly earnings results on Monday, Aug-8-2016. The company reported $-0.12 earnings per share for the quarter, missing the analyst consensus estimate by $-0.08. Analysts had a consensus of $-0.04. The company posted revenue of $89.50 million in the period, compared to analysts expectations of $79.68 million. The company’s revenue was up 38.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.

Zeltiq Aesthetics Inc opened for trading at $34.71 and hit $35.12 on the upside on Friday, eventually ending the session at $35.09, with a gain of 1.71% or 0.59 points. The heightened volatility saw the trading volume jump to 8,04,782 shares. Company has a market cap of $1,384 M.

In a different news, on Aug 5, 2016, Keith J Sullivan (CCO, President, North America) sold 8,000 shares at $34.38 per share price. According to the SEC, on Jul 14, 2016, Mark J Foley (President and CEO) sold 10,000 shares at $31.52 per share price. On Jul 12, 2016, Bradley Hauser (VP, Research and Development) sold 3,000 shares at $30.02 per share price, according to the Form-4 filing with the securities and exchange commission.

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Zeltiq Aesthetics Inc

Leave a Reply

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.